Scios Nova Inc. of Mountain View, Calif., which was formed bythe approved merger of Scios Inc. and Nova PharmaceuticalCorp., named to its eight-member board five existing Sciosdirectors, including John W. Cullingan, who continues aschairman. Joining the board from Nova were Hans Mueller,Nova's former chief executive officer and now vice chairman ofthe combined company, and former Nova directors Donald E.O'Neill and Solomon Snyder.
Embrex Inc. of Research Triangle Park, N.C., named Jonathan L.Schaeffer to the newly created position of director forregulatory affairs. Schaeffer was project manager forregulatory affairs at Pfizer Central Research.
Cell Genesys Inc. of Foster City, Calif., named Krisztina M.Zsebo director of research for cellular therapy. She was aresearch scientist and associate director of productdevelopment for hematopoietic stem cell factor at Amgen Inc.
Noven Pharmaceuticals Inc. of Miami named William A. Pecoravice president of finance and chief financial officer. Pecoraheld the same positions at Elexis Corp.
Carrington Laboratories Inc. of Irving, Texas, named Stephen G.Madison to the new position of senior vice president formarketing and sales. He was director of marketing andbusiness development in Latin America for Bristol-MyersSquibb Co.
Liposome Technology Inc. of Menlo Park, Calif., named David A.DeLong product director for marketing. DeLong had been withGenentech Inc. as product manager for Activase.
Genentech Inc. of South San Francisco, Calif., named LindaFayne Levinson to its board of directors. Levinson is a memberof Wings Partners, a merchant bank in Los Angeles.
Bio-Imaging Technologies Ind of W. Trenton, N.J., namedWilliam A. Wegener to the new position of director oftechnologies. He was assistant director for cardiology in theR&D division of Centocor Inc.
Synergen Inc. of Boulder, Colo., promoted James L. Redenbargerto vice president for operations and named Sharon Tetlowtreasurer and Barbara Dau Hoffman director of businessdevelopment. Tetlow had been with Genentech, and Hoffmanwas with INVESCO Trust Co.
Telor Ophthalmic Pharmaceuticals Inc. of Woburn, Mass., namedWalter P. Rahn II controller. Rahn had been corporateaccounting manager with SmithKline Beecham Corp.
Crop Genetics International of Hanover, Md., named Nikolai vanBeek manager of virus research and Gerald Delaney director ofvirus production in its insecticidal virus products division.Van Beek had been senior scientist with Sandoz Agro Inc., andDelaney was senior production microbiologist for Miles Inc.
(c) 1997 American Health Consultants. All rights reserved.